Sera Prognostics (SERA) Non Operating Income (2020 - 2026)
Sera Prognostics (SERA) posted Non Operating Income of $963000.0 for Q1 2026, down 10.34% on a QoQ basis from $1.1 million in Q4 2025, and down 9.75% year-over-year from $1.1 million in Q1 2025.
Sera Prognostics (SERA) Non Operating Income (2020 - 2026) Analysis & Trends
Sera Prognostics' Non Operating Income history runs 7 years deep, the most recent figure standing at $963000.0 for Q1 2026.
- Quarterly Non Operating Income fell 9.75% year-over-year to $963000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 17.21% YoY) and the FY2025 annual result came in at $4.6 million, up 21.78% from the prior year.
- Non Operating Income was $963000.0 for Q1 2026 at Sera Prognostics, down from $1.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $1.3 million in Q2 2025 and bottomed at $96000.0 in Q1 2022.
- A 5-year average of $851411.8 and a median of $948000.0 in 2024 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 2159.09% in 2022, while the deepest fall reached 77.24% in 2022.
- Sera Prognostics' Non Operating Income stood at $690000.0 in 2022, then jumped by 35.36% to $934000.0 in 2023, then decreased by 8.99% to $850000.0 in 2024, then climbed by 26.35% to $1.1 million in 2025, then fell by 10.34% to $963000.0 in 2026.
- Business Quant data shows SERA's Non Operating Income at $963000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sera Prognostics | 109.06 Mn | 109.06 Mn | -28,000.00 | 963,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 963,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 850,000.00 |
| Sep 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 958,000.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 934,000.00 |
| Sep 30, 2023 | 988,000.00 |
| Jun 30, 2023 | 932,000.00 |
| Mar 31, 2023 | 780,000.00 |
| Dec 31, 2022 | 690,000.00 |
| Sep 30, 2022 | 497,000.00 |
| Jun 30, 2022 | 244,000.00 |
| Mar 31, 2022 | 96,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 1.07 Mn |